Answers are grounded in this paper and cite their sources.
The selective hydrogenation of indole (IN) to indoline (INE) by rhodium and ruthenium catalysts modified with the tripodal polyphosphine ligand MeC(CH 2 PPh 2 ) 3 (triphos) has been investigated in the homogeneous phase. Both [Rh(DMAD)(triphos)]PF 6 (DMAD = dimethyl acetylenedicarboxylate) and [Ru(MeCN) 3 (triphos)](SO 3 CF 3 ) 2 have been found to generate effective catalysts for the conversion of IN to INE in THF in the presence of triflic acid. The protic acid is required to generate the 3 H -indolium cation, which contains a localized C N bond. The rhodium precursor was more efficient than the ruthenium species and allowed for hydrogenation of the substrate even at 60 °C with turnover frequencies as high as 100. Catalytic experiments in autoclaves and in high-pressure sapphire NMR tubes have provided valuable information on the hydrogenation mechanism of IN.
No takes yet. Share an insight, caveat, or question.
Barbaro et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: